CCL5 and neoplasm: HCMV also encodes pUL21.5, a small peptide that antagonizes the activity of the cytokine CCL5 (RANTES), which, while important in the T-cell response to chronic infection [49,56], has been implicated as a pro-inflammatory mediator of tumour progression [57].